Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 4.01 USD 4.7% Market Closed
Market Cap: $1.2B

During the last 3 months Abcellera Biologics Inc insiders bought 276.4k USD , and have not sold any shares. The stock price has dropped by 4% over this period (open performance analysis).

The last transaction was made on Feb 27, 2026 by Thermopylae Holdings Ltd. , who bought 130.7k USD worth of ABCL shares.

Last Transactions:
Booth Andrew
$+145.7k
Thermopylae Holdings Ltd.
$+130.7k
Montalbano John S.
$+178.5k
Thermopylae Holdings Ltd.
$+742.2k
Montalbano John S.
$+57.5k
Montalbano John S.
$+140.6k
Thermopylae Holdings Ltd.
$+740k
Montalbano John S.
$+44.6k
Montalbano John S.
$+92.8k
Hayden Michael R
$+98.2k
Lecault Veronique
$+103.8k
Hayden Michael R
$+177k
Thermopylae Holdings Ltd.
$+997.7k
Booth Andrew
$+99.3k
Thermopylae Holdings Ltd.
$+859.2k
Thermopylae Holdings Ltd.
$+2.3m
Thermopylae Holdings Ltd.
$+73.8k
Thermopylae Holdings Ltd.
$+441.1k
Thermopylae Holdings Ltd.
$+484k
Lecault Veronique
$+1.3m
Thermopylae Holdings Ltd.
$+2.2m
Thermopylae Holdings Ltd.
$+9m
Booth Andrew
$+492.2k
Montalbano John S.
$+85.4k
Montalbano John S.
$+181k
Lecault Veronique
$+2m
Lo Andrew
$+1.2m
Thermopylae Holdings Ltd.
$+3m
Booth Andrew
$+788.6k
Hamer John
$-2.3m
Hamer John
$-2.8m
Montalbano John S.
$+103.4k
View All Transactions

During the last 3 months Abcellera Biologics Inc insiders bought 276.4k USD , and have not sold any shares. The stock price has dropped by 4% over this period (open performance analysis).

The last transaction was made on Feb 27, 2026 by Thermopylae Holdings Ltd. , who bought 130.7k USD worth of ABCL shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
2
276.4k USD
3-6
months
1
178.5k USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Abcellera Biologics Inc
Insider Trading Chart

Abcellera Biologics Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Abcellera Biologics Inc
Last Insider Transactions

Global
Insiders Monitor

Abcellera Biologics Inc
Glance View

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. The company is headquartered in Vancouver, British Columbia and currently employs 386 full-time employees. The company went IPO on 2020-12-11. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.

ABCL Intrinsic Value
LOCKED
Unlock

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett